LTCR‑C2‑1
Chronic HBV infection
Pre‑clinicalUpcoming
Key Facts
About Lion TCR
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profileChronic HBV infection
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profile